GlobeNewswire

Placetel is named as a leading UC solution in Germany by ISG Experton Group

Dela
  • Placetel, Powered by BroadSoft, named as a leader in the "ISG Provider Lens Germany 2017 - Cloud Transformation / Operation Services & XaaS"
  • Study recognizes broad functional spectrum and strong focus on SMEs
  • Operation of data centers in Germany is acknowledged as a further advantage

COLOGNE, Germany, July 24, 2017 (GLOBE NEWSWIRE) --  Placetel, a cloud PBX service from BroadSoft Germany GmbH, has been named by ISG/Experton Group, a leading fully integrated research, advisory and consulting company, as one of the best cloud-based solutions for Unified Communications as a Service (UCaaS) in Germany. ISG/Experton Group positioned Placetel, powered by BroadSoft, in the leadership quadrant in its provider comparison "ISG Provider Lens Germany 2017 - Cloud Transformation / Operation Services & XaaS".

An infographic accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/38c74af2-ebc5-4f44-9e54-390eea52e0d0

Oliver Giering, Advisor of ISG/Experton Group and lead advisor of the study said: "Placetel has developed very well over the previous year and is therefore represented among some major players in the Leadership Quadrant of our study. In the rapidly growing UC market, there is still great potential for the Placetel offering."

Peter Nowack, general manager and vice president, BroadCloud Retail explains: "UCaaS is becoming the new core of business communications. Therefore, we are particularly proud of this recognition from ISG. Our position in the leadership quadrant further confirms the opportunity to expand our solutions and align them closely to the needs and demanding requirements of our customers."

Not only did ISG praise the Placetel offering for its broad functional spectrums, but also BroadSoft Germany's large customer base for PBX systems from the cloud, as well as its strong focus on medium-sized enterprises. According to ISG, new solutions for business communication have been on the rise, especially for small and medium-sized companies - not least due to the changeover from ISDN to the All-IP network. In addition, the consulting firm appreciated that Placetel is operated via computer centers in Germany.  "For many of our customers, this is particularly important for data availability and security," said Peter Nowack.

Due to market trends and strong growth, ISG has evaluated the UCaaS topic for the first time this year. UCaaS means the cloud-based integration of various communication channels, collaboration solutions and other applications on a single platform. Thus, UCaaS is of crucial importance for modern business communication.

Find further information of the study at www.placetel.de/cloudleader2017

Details of the study

On the basis of the provider comparison "Cloud Transformation / Operation Services & XaaS ISG Vendor Benchmark 2017, the Experton Group is able to provide in its meanwhile 8th edition a detailed and differentiated overview of the most important cloud providers in the German-speaking market to CIOs and IT managers. Furthermore, the study provides effective support in order to evaluate and select suitable cloud vendors and providers. It comprises twelve market categories for Germany as well as six market categories for Switzerland and evaluates more than 150 relevant suppliers.

About Placetel

Placetel is a leading cloud PBX offering, which is provided by BroadSoft Germany GmbH, a subsidiary of BroadSoft, Inc. The multiple award-winning Placetel telephone system is primarily aimed at small and medium-sized businesses. More than 15,000 business customers have already opted for the Placetel cloud PBX solution, which contains more than 150 powerful features and is characterized by its high level of flexibility. According to ISG Experton Group, Placetel is one of the best cloud-based offerings for Unified Communications as a Service (UCaaS) in Germany. For more information about Placetel please click here: www.placetel.de | Twitter | LinkedIn | Placetel Blog

About BroadSoft, Inc.

BroadSoft, Inc. (NASDAQ:BSFT) is the technology innovator in cloud unified communications, team collaboration, and contact center solutions for businesses and service providers across 80 countries. We are the market share leader for cloud unified communications with an open, mobile and secure platform trusted by 25 of the world's top 30 service providers by revenue. Our BroadSoft Business application suite empowers users and teams to share ideas and work simply to achieve breakthrough performance. For additional information, visit www.BroadSoft.com.

Twitter | LinkedIn | BroadSoft Blog

Presse-Kontakt:
Placetel / BroadSoft Germany GmbH
Franziska Huschka
Lothringer Straße 56
50677 Köln
Deutschland
Tel.: +49 221-9999 856 0
E-Mail: fhuschka@broadsoft.com
Internet: www.placetel.de

PR-Agentur:
Donner & Doria Public Relations GmbH
Daniel Impertro
Gaisbergstraße 16
D-69115 Heidelberg
Telefon: +49 6221-58787-34
E-Mail: daniel.impertro@donner-doria.de
Internet: www.donner-doria.de

 



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: BroadSoft, Inc. via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Investerarmöten våren 201915.2.2019 08:46:00Pressmeddelande

15 februari 2019 PRESSRELEASE Arcoma har som ambition att fortsätta öka sitt aktieägarfokus och kontinuerligt förbättra kommunikationen med aktieägare. Under våren 2019 kommer Arcoma medverka på flertalet investerarmöten där aktuella händelser och aktiviteter presenteras. Här ges en ökad inblick i bolagets vision och strategier samt en möjlighet till att ställa frågor till bolagets ledning. SvD Börsplus Temadag "Dubblare" Dag, tid och plats: 5 mars, kl. 13.00, GT 30, Grev Turegatan 30, Stockholm Stockholm Corporate Finance Life Science event Dag, tid och plats: 14 mars, kl. 07.30, Berns, Kammarsalen, Stockholm Redeyes Medtech & Diagnostics event Dag, tid och plats: 14:e maj, Redeye, Mäster Samuelsgatan 42, Stockholm För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soderqvist at arcoma.se Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalite

Corline Biomedical AB: Första patient doserad med Renaparin®15.2.2019 08:42:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man inkluderat första patienten i fas 1-studien RENAPAIR 01. Patienten inkluderades vid transplantationsavdelningen på Uppsala Akademiska sjukhus. Renaparin® är en produkt under utveckling för att förbättra njurtransplantation. I Corlines studie RENAPAIR 01 utvärderas produkten med avseende på tolerabilitet och säkerhet. Studien öppnades för patientrekrytering i slutet av 2018 och första patient är nu doserad och inkluderad i studien. Totalt skall 18 patienter rekryteras och när de 4 första patienterna är utvärderade i Uppsala, öppnas också Karolinska Universitetssjukhuset i Huddinge för rekrytering till studien. Henrik Nittmar, VD i Corline Biomedical AB, kommenterar "Det händer mycket i Corline för tillfället och alla arbetar hårt för att målbilden i bolaget skall uppfyllas. Det gäller såväl vår interna organisation som våra externa samarbetspartners. Därför är det extra roligt när vi når avgörande milstolpar i utvec

Corline Biomedical AB: Rekryterar Lars Olsson som Head of CMC14.2.2019 12:44:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man rekryterat Lars Olsson till den nyinrättade tjänsten som Head of CMC (Chemistry, Manufacturing & Control). Lars Olsson hade tidigare samma tjänst hos Wilson Therapeutics AB, som under 2018 förvärvades av amerikanska Alexion. Lars Olsson kommer att ansvara för Corlines samtliga aktiviteter inom tillverkning och kontroll relaterat till bolagets läkemedelsprodukter, med särskilt fokus på Renaparin® inför kommande fas 2- och fas 3-utveckling. I slutet av 2018 meddelade Corline att patientrekryteringen startar i bolagets fas 1-studie RENAPAIR 01, där produkten Renaparin®, som är under utveckling för att förbättra utfallet av njurtransplantation, utvärderas med avseende på tolerabilitet och säkerhet. Därmed tog en ny utvecklingsfas vid i bolaget i vilken alltmer resurser fokuseras på att förbereda den fortsatta kliniska utvecklingen av produkten genom fas 2 och fas 3 i syfte att slutligen kunna registrera produkten för k

Arcoma AB: Canon och Arcoma tecknar distributörsavtal för Turkiet14.2.2019 10:38:00Pressmeddelande

14 februari 2019 Canon Medical Systems i Turkiet och Arcoma har tecknat ett distributörsavtal som gör att Canon kommer att kunna sälja Arcomas produkter i Turkiet från och med den 15 februari 2019. Canon är sedan tidigare återförsäljare för Arcomas produkter i Nordamerika och utvalda länder i Europa. Detta samarbete utökas nu till Turkiet som är det första land i Canons Asien organisation att välja Arcoma som en formell partner. "Att vi stärker och formaliserar samarbetet med Canon även i Turkiet är ännu ett erkännande av Arcoma som leverantör av högkvalitativa röntgensystem. Canon i Turkiet förbereder ett flertal större upphandlingar till sjukhus där Arcomas lösningar ingår. Avtal som detta ingår i Arcomas strategi att utöka med nya försäljningskanaler och att expandera till nya länder för att skapa framtida tillväxt." kommenterar Arcomas VD, Jesper Söderqvist. För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soder

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum